Randomized, double-blind trial of F14512, a polyamine-vectorized anticancer drug, compared with etoposide phosphate, in dogs with naturally occurring lymphoma

Oncotarget
Pierre BoyéBruno Gomes

Abstract

Purpose: F14512 is an epipodophyllotoxin derivative from etoposide, combined with a spermine moiety introduced as a cell delivery vector. The objective of this study was to compare the safety and antitumor activity of F14512 and etoposide phosphate in dogs with spontaneous non-Hodgkin lymphoma (NHL) and to investigate the potential benefit of F14512 in P-glycoprotein (Pgp) overexpressing lymphomas. Experimental Design: Forty-eight client-owned dogs with intermediate to high-grade NHL were enrolled into a randomized, double-blind trial of F14512 versus etoposide phosphate. Endpoints included safety and therapeutic efficacy. Results: Twenty-five dogs were randomized to receive F14512 and 23 dogs to receive etoposide phosphate. All adverse events (AEs) were reversible, and no treatment-related death was reported. Hematologic AEs were more severe with F14512 and gastrointestinal AEs were more frequent with etoposide phosphate. F14512 exhibited similar response rate and progression-free survival (PFS) as etoposide phosphate in the global treated population. Subgroup analysis of dogs with Pgp-overexpressing NHL showed a significant improvement in PFS in dogs treated with F14512 compared with etoposide phosphate. Conclusion: F14512 sh...Continue Reading

References

Sep 1, 1990·Journal of Veterinary Internal Medicine·A E Hohenhaus, R E Matus
Dec 7, 2000·Cancer Investigation·D M Vail, E G MacEwen
Mar 21, 2002·Expert Review of Molecular Diagnostics·K L O'NeillB K Murray
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Jul 3, 2002·Journal of the American Veterinary Medical Association·Anthony J MutsaersDeborah W Knapp
May 6, 2006·Methods in Molecular Biology·Xuan Huang, Zbigniew Darzynkiewicz
Sep 25, 2009·Investigational New Drugs·Anna KruczynskiNicolas Guilbaud
Mar 17, 2010·Veterinary and Comparative Oncology·D M VailUNKNOWN Veterinary Cooperative Oncology Group
Mar 29, 2011·Trends in Molecular Medicine·Jennie L RowellCarlos E Alvarez
Aug 19, 2011·Veterinary and Comparative Oncology·S LynchD J Argyle
Dec 1, 2011·Apoptosis : an International Journal on Programmed Cell Death·Caroline BallotPhilippe Marchetti
Mar 29, 2013·Journal of the American Animal Hospital Association·Ravinder S DhaliwalNikolaos G Dervisis
Sep 21, 2013·Journal of the American Animal Hospital Association·Mary Lynn HigginbothamDiana Burr
Mar 20, 2014·Veterinary Immunology and Immunopathology·Daisuke ItoJaime F Modiano
May 2, 2014·Ecotoxicology and Environmental Safety·Marko GerićVera Garaj-Vrhovac
Jul 1, 2014·Toxicology in Vitro : an International Journal Published in Association with BIBRA·M ZandvlietJ A Schrickx
Jan 3, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Rishil J KathawalaZhe-Sheng Chen
May 2, 2015·Polish Journal of Veterinary Sciences·J SokołowskaR Lechowski
Jul 15, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dominique TiernyBruno Gomes
Feb 5, 2016·Science Translational Medicine·Amy K LeBlancChand Khanna
Apr 25, 2017·Veterinary Sciences·Davis M SeeligMichael A Linden
Feb 18, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Imran Shair MohammadLifang Yin
Apr 13, 2018·Clinica Chimica Acta; International Journal of Clinical Chemistry·Bin LiuJianmin Yang

❮ Previous
Next ❯

Citations

Jul 10, 2020·Veterinary and Comparative Oncology·Pierre BoyéDominique Tierny

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
xenograft
xenografts
FCS
ELISA

Software Mentioned

SPSS

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.